An open‐label, investigator‐initiated, single‐center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot‐preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation

BACKGROUND: Melasma is a common skin disorder characterized by alterations in normal skin pigmentation. The objective was to evaluate the efficacy and safety of a skin whitening serum containing niacinamide, hydroxyphenoxy propionic acid, dipotassium glycyrrhizate, glycolic acid, and 4‐n‐butylresorc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantelli, Mariateresa, Ferrillo, Maria, Granger, Corinne, Fabbrocini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Skin Care Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290795/
https://www.ncbi.nlm.nih.gov/pubmed/34087055
http://dx.doi.org/10.1111/jocd.14271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290795/
https://www.ncbi.nlm.nih.gov/pubmed/34087055
http://dx.doi.org/10.1111/jocd.14271

Ejemplares similares